Showing results (11-20 of 128) with videos related to
Sort By:
Pageof 13
Annals of Translational Medicine|October 24, 2017
Expanded molecular interrogation for potential actionable targets in non-squamous non-small cell lung cancerKah Weng Lau, Claudia Seng, Tony K H Lim, et al.Nature Reviews. Clinical Oncology|November 15, 2017
Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapesAlexander Drilon, Zishuo I Hu, Gillianne G Y Lai, et al.Nature Reviews. Clinical Oncology|November 29, 2017
Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapesAlexander Drilon, Zishuo I Hu, Gillianne G Y Lai, et al.Cancer Treatment Reviews|February 8, 2022
Efficacy of targeted therapies for oncogene-driven lung cancer in early single-arm versus late phase randomized clinical trials: A comparative analysisAaron C Tan, Sze Huey Tan, Siqin Zhou, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 2, 2008
Primary tracheal lymphoma causing respiratory failureDaniel S W Tan, Philip C T Eng, Soon Thye Lim, et al.Cancer Discovery|April 4, 2024
Precision Endpoints for Contemporary Precision Oncology TrialsRegina Hoo, Kevin L M Chua, Pankaj Kumar Panda, et al.Nature Reviews. Clinical Oncology|November 29, 2024
The changing treatment landscape of EGFR-mutant non-small-cell lung cancerFei Zhou, Haoyue Guo, Yang Xia, et al.The Lancet. Oncology|November 4, 2021
Revisiting neoadjuvant therapy in non-small-cell lung cancerStephanie P L Saw, Boon-Hean Ong, Kevin L M Chua, et al.Cancer|November 10, 2009
Hepatitis B virus reactivation and role of antiviral prophylaxis in lymphoma patients with past hepatitis B virus infection who are receiving chemoimmunotherapyYu Xuan Koo, Daniel S W Tan, Iain B Tan, et al.World Journal of Gastroenterology|August 13, 2009
"Anti-HBc alone" in human immunodeficiency virus-positive and immuno-suppressed lymphoma patientsYu Xuan Koo, Daniel S W Tan, Iain B H Tan, et al.Pageof 13